| Identification | Back Directory | [Name]
4-[(AR*)-ALPHA-((2S*,5R*)-4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-HYDROXYBENZYL]-N,N-DIETHYLBENZAMIDE | [CAS]
155836-52-5 | [Synonyms]
BW 373U86
BW373U86 HYDROCHLORIDE
4-((aR*)-a-((2S*,5R*)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N,N-diethylbenzamide
4-[(αR*)-α-((2S*,5R*)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl]-N,N-diethylbenzamide
4-[(AR*)-α-((2S*,5R*)-4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-HYDROXYBENZYL]-N,N-DIETHYLBENZAMIDE
4-[(AR*)-ALPHA-((2S*,5R*)-4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-HYDROXYBENZYL]-N,N-DIETHYLBENZAMIDE | [Molecular Formula]
C27H37N3O2 | [MDL Number]
MFCD06798378 | [MOL File]
155836-52-5.mol | [Molecular Weight]
435.6 |
| Hazard Information | Back Directory | [Uses]
BW 373U86 is a δ opioid receptor-?selective racemic agonist. | [Definition]
ChEBI: 4-[(R)-[(2S,5R)-2,5-dimethyl-4-prop-2-enyl-1-piperazinyl]-(3-hydroxyphenyl)methyl]-N,N-diethylbenzamide is a diarylmethane. | [Biological Activity]
Potent, selective non-peptide δ -opioid receptor agonist. K i values are 1.8, 15 and 34 nM for δ , μ and κ receptors respectively. Centrally active following systemic administration in vivo . |
|
|